Peregrine Pharma (PPHM) Reports Q4 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Selling, general and administrative: 5.06M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Selling, general and administrative: 5.06M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Peregrine Pharma (NASDAQ: PPHM) reported Q4 EPS of ($0.16), versus ($0.40) reported last year. Revenue for the quarter came in at $17.9 million, versus $18.78 million reported last year.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- FactSet (FDS) Tops Q4 EPS by 17c, Beats on Revenue; Offers FY Guidance
- Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
